© 1993 Oxford University Press
OTHER |
Charcot Marie Tooth neuropathy type 1A with both duplication and non-duplication
Division of Medical Genetics, Department of Pediatrics, University of lowa lowa City, A 52242 1Genetic Epidemiology, University of Utah Salt Lake City, UT 84108, USA
* To whom correspondence should be addressed
Received December 7, 1992; Revised February 4, 1993; Accepted February 4, 1993
We studied a family with nine of twenty members affected with Charcot Marie Tooth disease type 1A (CMT1A). The proband and her four affected sibs showed no duplication of the 17p11.2p12 (CMT region). Two of the proband's affected daughters and three affected grandchildren showed duplication of the PMP-22 gene and of the marker VAW409R3 but not of the markers VAW412R3 and EW401. Pulsed field gel electrophoresis (PFGE) revealed a 220 kb SacII fragment in one CMT1A patient with duplication instead of a 500 kb SacII fragment as previously reported (1, 3, 4, 69). Our findings suggest a smaller size of the duplication in this CMT1A family. The disease segregates with the same haplotype in both duplicated and nonduplicated CMT1A patients. The clinical phenotype showed more severe weakness with earlier onset and motor nerve conduction velocities were characterized by more significant slowing in the patients with duplication than in the patients who did not show duplication.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Katona, X. Wu, S. M. E. Feely, S. Sottile, C. E. Siskind, L. J. Miller, M. E. Shy, and J. Li PMP22 expression in dermal nerve myelin from patients with CMT1A Brain, July 1, 2009; 132(7): 1734 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, J. Kleeff, I. Esposito, H. Kayed, K. Felix, T. Giese, M. W. Buchler, and H. Friess Expression Analysis of PMP22/Gas3 in Premalignant and Malignant Pancreatic Lesions J. Histochem. Cytochem., July 1, 2005; 53(7): 885 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue, K. Dewar, N. Katsanis, L. T. Reiter, E. S. Lander, K. L. Devon, D. W. Wyman, J. R. Lupski, and B. Birren The 1.4-Mb CMT1A Duplication/HNPP Deletion Genomic Region Reveals Unique Genome Architectural Features and Provides Insights into the Recent Evolution of New Genes Genome Res., June 1, 2001; 11(6): 1018 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. North NEW PERSPECTIVES IN PEDIATRIC NEUROMUSCULAR DISORDERS Hotel Intercontinental Sydney, Sydney, Australia, August 28, 1998 J Child Neurol, January 1, 1999; 14(1): 26 - 57. [PDF] |
||||
![]() |
F. R. DIETZ and K. D. MATHEWS Current Concepts Review - Update on the Genetic Bases of Disorders with Orthopaedic Manifestations J. Bone Joint Surg. Am., October 1, 1996; 78(10): 1583 - 98. [Full Text] |
||||
![]() |
L.E. Warner, L.T. Reiter, T. Murakami, and J.R. Lupski Molecular Mechanisms for Charcot-Marie-Tooth Disease and Related Demyelinating Peripheral Neuropathies Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 659 - 671. [Abstract] [PDF] |
||||
![]() |
E Fabbretti, P Edomi, C Brancolini, and C Schneider Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes & Dev., August 1, 1995; 9(15): 1846 - 1856. [Abstract] [PDF] |
||||






